10.25384/SAGE.11298278.v1 Francesca Morgante Francesca Morgante Ganesh Bavikatte Ganesh Bavikatte Fahim Anwar Fahim Anwar Biju Mohamed Biju Mohamed APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4 – Supplemental material for The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) SAGE Journals 2019 sialorrhoea botulinum toxin incobotulinumtoxinA Parkinson’s disease Motor neuron disease 2019-11-29 13:06:12 Journal contribution https://sage.figshare.com/articles/journal_contribution/APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4_Supplemental_material_for_The_burden_of_sialorrhoea_in_chronic_neurological_conditions_current_treatment_options_and_the_role_of_incobotulinumtoxinA_Xeomin_/11298278 <p>Supplemental material, APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4 for The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) by Francesca Morgante, Ganesh Bavikatte, Fahim Anwar and Biju Mohamed in Therapeutic Advances in Neurological Disorders</p>